ADS051 is the first and only MRP2 / FPR1 inhibitor to demonstrate favorable safety and tolerability with signals of clinical efficacy with relief from disruptive symptoms of inflammatory bowel disease ...
Schematic diagram (a) and photo (b) of the fabricated gas-filled hollow-core fiber phase modulator. (c) Measured loss spectrum and (d) transient response of the phase modulator. Credit: ...
This study demonstrates a compact optical modulation platform that enables real-time, high-resolution spectroscopy using sub-MHz interleaved combs generated via chip-scale acousto-optic phase ...
WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results